Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
9,853,493
-
Share change
-
-2,462,415
-
Total reported value
-
$16,752,000
-
Put/Call ratio
-
67%
-
Price per share
-
$1.70
-
Number of holders
-
35
-
Value change
-
-$4,957,108
-
Number of buys
-
14
-
Number of sells
-
26
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2017
As of 30 Sep 2017,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,853,493 shares.
The largest 10 holders included
Wildcat Capital Management, LLC, VANGUARD GROUP INC, Intellectus Partners, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.